Tech Company Financing Transactions

ALDEA Pharma Funding Round

Canaan Partners participated in a $2 million funding round for ALDEA Pharma. The round closed on 3/31/2013.

Transaction Overview

Company Name
Announced On
3/31/2013
Transaction Type
Venture Equity
Amount
$2,000,000
Round
Undisclosed
Investors

Canaan Partners (Timothy Shannon)

Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3696 Haven Ave. C
Redwood City, CA 94566
USA
Email Address
Overview
ALDEA Pharmaceuticals develops small-molecule modulators of the ALDH family for the treatment of toxic aldehyde-related diseases.
Profile
ALDEA Pharma LinkedIn Company Profile
Social Media
ALDEA Pharma Company Twitter Account
Company News
ALDEA Pharma News
Facebook
ALDEA Pharma on Facebook
YouTube
ALDEA Pharma on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
William Yelle
  William Yelle LinkedIn Profile  William Yelle Twitter Account  William Yelle News  William Yelle on Facebook
Chief Medical Officer
Richard Shames
  Richard Shames LinkedIn Profile  Richard Shames Twitter Account  Richard Shames News  Richard Shames on Facebook
VP - R & D
Wenjin Yang
  Wenjin Yang LinkedIn Profile  Wenjin Yang Twitter Account  Wenjin Yang News  Wenjin Yang on Facebook


 

 

Browse more venture capital transactions:

Prev: 3/31/2013: SeeControl venture capital transaction
Next: 3/31/2013: Dashboard.io venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to report on every notable VC transaction. All VC database entries on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary